0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  ONLINE FIRST
Sanja Percac-Lima, MD, PhD; Jeffrey M. Ashburner, PhD, MPH; Adrian H. Zai, MD, MPH, PhD; et al.
JAMA Intern Med. Published online June 06, 2016. doi:10.1001/jamainternmed.2016.0841
Includes: Supplemental Content

Invited Commentary |  ONLINE FIRST
Laura Esserman, MD, MBA
JAMA Intern Med. Published online May 31, 2016. doi:10.1001/jamainternmed.2016.2257

Perspective |  ONLINE FIRST
Jan Vick Harris
JAMA Intern Med. Published online May 31, 2016. doi:10.1001/jamainternmed.2016.2254

From The JAMA Network | 
Karla Kerlikowske, MD
JAMA Intern Med. 2015;175(12):1970-1971. doi:10.1001/jamainternmed.2015.6466.

Original Investigation | 
Estefanía Toledo, MD, MPH, PhD; Jordi Salas-Salvadó, MD, PhD; Carolina Donat-Vargas, PharmD; et al.
JAMA Intern Med. 2015;175(11):1752-1760. doi:10.1001/jamainternmed.2015.4838.
Includes: Supplemental Content

Invited Commentary | 
Joshua J. Fenton, MD, MPH
JAMA Intern Med. 2015;175(11):1837-1838. doi:10.1001/jamainternmed.2015.5319.

Original Investigation | 
Constance D. Lehman, MD, PhD; Robert D. Wellman, MS; Diana S. M. Buist, PhD; et al.
JAMA Intern Med. 2015;175(11):1828-1837. doi:10.1001/jamainternmed.2015.5231.

Invited Commentary | 
Joann G. Elmore, MD, MPH; Ruth Etzioni, PhD
JAMA Intern Med. 2015;175(9):1490-1491. doi:10.1001/jamainternmed.2015.3056.

Original Investigation | 
Charles Harding, AB; Francesco Pompei, PhD; Dmitriy Burmistrov, PhD; et al.
JAMA Intern Med. 2015;175(9):1483-1489. doi:10.1001/jamainternmed.2015.3043.
Includes: CME, Supplemental Content

Viewpoint | 
Jennifer S. Haas, MD, MSc; Celia P. Kaplan, DrPH, MA
JAMA Intern Med. 2015;175(9):1439-1440. doi:10.1001/jamainternmed.2015.3040.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD